Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood - Trial NCT06245512
Access comprehensive clinical trial information for NCT06245512 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut National de la Santé Et de la Recherche Médicale, France and is currently Not yet recruiting. The study focuses on Endometriosis. Target enrollment is 250 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Institut National de la Santé Et de la Recherche Médicale, France
Timeline & Enrollment
N/A
Mar 01, 2024
Oct 01, 2027
Primary Outcome
Diagnostic and prognostic score
Summary
The goal of this observational study is to identify diagnostic and prognostic biomarkers for
 endometriosis using menstrual blood, an easily accessible yet overlooked biological fluid in
 women of reproductive age, affected or not by endometriosis
 
 The main questions it aims to answer are:
 
 - are there relevant differences in the menstrual blood of women affected by endometriosis
 compared to women without endometriosis?
 
 - do some of these differences disappear or lessen when the disease is treated by surgery?
 Participants will answer questions relevant to endometriosis and provide menstrual blood
 1 to 3 times (self-collected with a menstrual cup). A subgroup of participants affected
 by endometriosis that will undergo surgery for their regular care will provide menstrual
 blood before and after their surgery.
 
 Researchers will compare the menstrual blood of women with and without endometriosis, and
 before and after surgery to see if they can identify significant differences.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06245512
Non-Device Trial